Background Thymic carcinoma, a rare malignancy in the mediastinum, currently lacks
standardized treatment options. Although surgery remains a crucial component among …

Thymic carcinoma (TC) is a rare malignant tumor with a poor prognosis, and there is
currently limited data on the use of immunotherapy in patients with unresectable TC. In this …

Simple Summary Thymic carcinoma is a rare cancer, and its biology remains largely
unknown. Although complete surgical resection is a standard treatment for thymic …

Background Thymic carcinoma is a rare disease with an incidence of around 0.5 cases per
million with a poor prognosis. The aim of this study was to assess patient outcomes with …

Introduction Thymic carcinoma is a rare malignancy often presenting at an advanced stage.
Radiation therapy and chemotherapy are often the only treatment options available to …

Thymic carcinoma is a rare type of cancer that is more aggressive and is associated with a
poorer prognosis compared with thymoma. No definitive clinical management of this disease …

Background Thymic carcinomas are aggressive and difficult to treat a subset of thymic
epithelial tumours that represent a heterogeneous group of rare intrathoracic malignancies …

The optimal therapy for advanced thymic carcinoma has long been controversial. Despite
that complete (R0) resection is recommend as the first-line treatment, multidisciplinary …

Thymic carcinoma (TC) is a rare and aggressive malignancy of the thymus associated with
less than 25% 5 years survivability. Our case report showcases the successful treatment of …

Background Thymic carcinoma (TC) is a rare, aggressive cancer without a standardized
therapeutic approach in the metastatic context. Recently TCs have been shown to express …